NCT00083681View on ClinicalTrials.gov

DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 30, 1998

Study Completion Date

May 31, 2005

Conditions
Multiple Myeloma
Interventions
DRUG

Thalidomide

DRUG

Dexamethasone

DRUG

Cytoxan

DRUG

Etoposide

DRUG

Cisplatin

DRUG

G-CSF

Trial Locations (1)

72205

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00083681 - DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | Biotech Hunter | Biotech Hunter